The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)
Open Access
- 21 December 2021
- journal article
- research article
- Published by Wiley in Brain and Behavior
- Vol. 12 (1) , e2465
Abstract
Background: Targeting leptin could represent a rational strategy to treat amyotrophic lateral sclerosis (ALS), as previously clinical studies have shown its levels to be associated with a lower risk of ALS disease. However, very little is known about the potential influence of leptin in altering disease progression in ALS, as it has thus far been correlated with the protection exerted by increased fat mass stores.Methods: We studied the impact of leptin treatment beginning at 42‐days of age (asymptomatic stage of disease) in the TDP‐43 (TDP43A315T) transgenic (Tg) ALS mouse model.Results: Our study shows that leptin treatment was associated with altered expression of adipokines and metabolic proteins in TDP43A315T mice. We also observed that weight loss decline was less prominent after leptin treatment in TDP43A315T mice relative to vehicle‐treated animals. In TDP43A315T mice treated with leptin the disease duration lasted longer along with an improvement in motor performance relative to vehicle‐treated animals.Conclusions: Collectively, our results support leptin as a potential novel treatment approach for ALS.Keywords
This publication has 60 references indexed in Scilit:
- Raise standards for preclinical cancer researchNature, 2012
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer diseaseNeurobiology of Aging, 2011
- Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosisMuscle & Nerve, 2011
- Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons ofTDP-43transgenic miceProceedings of the National Academy of Sciences, 2010
- TAR DNA-binding protein 43 in neurodegenerative diseaseNature Reviews Neurology, 2010
- Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cellsBiochemical and Biophysical Research Communications, 2010
- TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degenerationProceedings of the National Academy of Sciences, 2009
- Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory studyPhysiological Genomics, 2008
- Effects of leptin on memory processingPeptides, 2006
- The role of neuropeptide Y in the antiobesity action of the obese gene productNature, 1995